Clinical Trial Update: Oral Ketamine for Treatment of Vaso-Occlusive Pain [Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 3 study of oral ketamine for vaso-occlusive crisis pain in sickle cell disease, currently recruiting. Sponsored by Bo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Vaso-occlusive Crisis | Phase 3 | Status: RECRUITING